Agilon Health (NYSE:AGL) Sets New 12-Month High – Time to Buy?

Agilon Health, Inc. (NYSE:AGL)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $90.48 and last traded at $86.4310, with a volume of 399530 shares changing hands. The stock had previously closed at $81.73.

Analysts Set New Price Targets

Several equities analysts have commented on AGL shares. Robert W. Baird upped their price objective on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. TD Cowen reissued a “hold” rating and set a $55.00 price target (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Wells Fargo & Company reissued an “overweight” rating and set a $72.00 price target (up from $37.50) on shares of Agilon Health in a research report on Friday, May 8th. Finally, JPMorgan Chase & Co. downgraded Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target on the stock. in a research report on Monday, May 4th. Five investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $45.05.

Agilon Health Stock Down 8.4%

The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average price of $29.50 and a 200-day moving average price of $21.50. The firm has a market cap of $1.35 billion, a P/E ratio of -3.75 and a beta of 2.29.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. On average, equities analysts forecast that Agilon Health, Inc. will post -3.75 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of hedge funds have recently made changes to their positions in AGL. Goldman Sachs Group Inc. lifted its stake in shares of Agilon Health by 196.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after purchasing an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the last quarter. CenterBook Partners LP lifted its stake in shares of Agilon Health by 492.4% during the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares during the last quarter. North Peak Capital Management LLC lifted its stake in shares of Agilon Health by 10.8% during the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after purchasing an additional 3,715,460 shares during the last quarter. Finally, Voleon Capital Management LP lifted its stake in shares of Agilon Health by 5,519.2% during the 3rd quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock worth $2,823,000 after purchasing an additional 2,692,259 shares during the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.